Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Structural basis for AMP binding to mammalian AMP-activated protein kinase

Abstract

AMP-activated protein kinase (AMPK) regulates cellular metabolism in response to the availability of energy and is therefore a target for type II diabetes treatment1. It senses changes in the ratio of AMP/ATP by binding both species in a competitive manner2. Thus, increases in the concentration of AMP activate AMPK resulting in the phosphorylation and differential regulation of a series of downstream targets that control anabolic and catabolic pathways1,2. We report here the crystal structure of the regulatory fragment of mammalian AMPK in complexes with AMP and ATP. The phosphate groups of AMP/ATP lie in a groove on the surface of the γ domain, which is lined with basic residues, many of which are associated with disease-causing mutations. Structural and solution studies reveal that two sites on the γ domain bind either AMP or Mg·ATP, whereas a third site contains a tightly bound AMP that does not exchange. Our binding studies indicate that under physiological conditions AMPK mainly exists in its inactive form in complex with Mg·ATP, which is much more abundant than AMP. Our modelling studies suggest how changes in the concentration of AMP ([AMP]) enhance AMPK activity levels. The structure also suggests a mechanism for propagating AMP/ATP signalling whereby a phosphorylated residue from the α and/or β subunits binds to the γ subunit in the presence of AMP but not when ATP is bound.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structure of mammalian AMPK.
Figure 2: Fluorescence titrations of mant-AMP with AMPK.
Figure 3: Front and back views of the three adenyl moieties bound to the γ domain, shown in surface representation.
Figure 4: Interactions between primarily basic residues from γ with the phosphate groups of the three bound adenyl species.

Similar content being viewed by others

References

  1. Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15–25 (2005)

    Article  CAS  Google Scholar 

  2. Hardie, D. G., Carling, D. & Carlson, M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821–855 (1998)

    Article  CAS  Google Scholar 

  3. Hardie, D. G. & Carling, D. The AMP-activated protein kinase: Fuel gauge of the mammalian cell. Eur. J. Biochem. 246, 259–273 (1997)

    Article  CAS  Google Scholar 

  4. Yeh, L., Lee, K. & Kim, K. Regulation of rat liver acetyl-CoA carboxylase. Regulation of phosphorylation and inactivation of acetyl-CoA carboxylase by adenylate energy charge. J. Biol. Chem. 255, 2308–2314 (1980)

    CAS  PubMed  Google Scholar 

  5. Hardie, D. G., Carling, D. & Sim, A. T. R. The AMP-activated protein kinase-a multisubstrate regulator of lipid metabolism. Trends Biochem. Sci. 14, 20–23 (1989)

    Article  CAS  Google Scholar 

  6. Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569–574 (2004)

    Article  ADS  CAS  Google Scholar 

  7. Viollet, B. et al. The AMP-activated protein kinase α2 catalytic subunit controls whole body insulin sensitivity. J. Clin. Invest. 111, 91–98 (2003)

    Article  CAS  Google Scholar 

  8. Zong, H. et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl Acad. Sci. USA 99, 15983–15987 (2002)

    Article  ADS  CAS  Google Scholar 

  9. Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339–343 (2002)

    Article  ADS  CAS  Google Scholar 

  10. Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med. 8, 1288–1295 (2002)

    Article  CAS  Google Scholar 

  11. Watt, M. J. et al. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nature Med. 12, 541–548 (2006)

    Article  CAS  Google Scholar 

  12. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–1174 (2001)

    Article  CAS  Google Scholar 

  13. Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642–1646 (2005)

    Article  ADS  CAS  Google Scholar 

  14. Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A. & Carling, D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403, 139–148 (2007)

    Article  CAS  Google Scholar 

  15. Carling, D. The AMP-activated protein kinase cascade—a unifying system for energy control. Trends Biochem. Sci. 29, 18–24 (2004)

    Article  CAS  Google Scholar 

  16. Woods, A. et al. Characterization of AMP-activated protein kinase β subunit and γ subunit—assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271, 10282–10290 (1996)

    Article  CAS  Google Scholar 

  17. Hudson, E. R. et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13, 861–866 (2003)

    Article  CAS  Google Scholar 

  18. Iseli, T. J. et al. AMP-activated protein kinase β subunit tethers α and γ subunits by its C-terminal sequence (186–270). J. Biol. Chem. 280, 13395–13400 (2005)

    Article  CAS  Google Scholar 

  19. Townley, R. & Shapiro, L. Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science 315, 1726–1729 (2007)

    Article  ADS  CAS  Google Scholar 

  20. Rudolph, M. J., Amodeo, G. A., Bai, Y. & Tong, L. Crystal structure of the protein kinase domain of yeast AMP-activated protein kinase Snf1. Biochem. Biophys. Res. Commun. 337, 1224–1228 (2005)

    Article  CAS  Google Scholar 

  21. Corkey, B. E., Duszynski, J., Rich, T. L., Matschinsky, B. & Williamson, J. R. Regulation of free and bound magnesium in rat hepatocytes and isolated mitochondria. J. Biol. Chem. 261, 2567–2574 (1986)

    CAS  PubMed  Google Scholar 

  22. Scott, J. W. et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113, 274–284 (2004)

    Article  CAS  Google Scholar 

  23. Chen, Z. et al. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 279, 1202–1206 (2000)

    Article  Google Scholar 

  24. Fujii, N. et al. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem. Biophys. Res. Commun. 273, 1150–1155 (2000)

    Article  CAS  Google Scholar 

  25. McConell, G. K. et al. Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen. J. Physiol. 568, 665–676 (2005)

    Article  CAS  Google Scholar 

  26. Fryer, L. G., Parbu-Patel, A. & Carling, D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226–25232 (2002)

    Article  CAS  Google Scholar 

  27. Gollob, M. H. et al. Identification of a gene responsible for familial Wolff–Parkinson–White syndrome. N. Engl. J. Med. 344, 1823–1831 (2001)

    Article  CAS  Google Scholar 

  28. Arad, M. et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest. 109, 357–362 (2002)

    Article  CAS  Google Scholar 

  29. Blair, E., Redwood, C., Ashrafian, H., Ostman-Smith, I. & Watkins, H. Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10, 1215–1220 (2001)

    Article  CAS  Google Scholar 

  30. Adams, J. et al. Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site. Protein Sci. 13, 155–165 (2004)

    Article  CAS  Google Scholar 

  31. Neumann, D., Woods, A., Carling, D., Wallimann, T. & Schlattner, U. Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein Expr. Purif. 30, 230–237 (2003)

    Article  CAS  Google Scholar 

  32. Otwinowski, Z. & Minor, W. in Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 556–562 (SERC Daresbury Laboratory, Warrington, 1993)

    Google Scholar 

  33. Navaza, J. AMoRe: an Automated Package for Molecular Replacement. Acta Crystallogr. A 50, 157–163 (1994)

    Article  Google Scholar 

  34. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994)

  35. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998)

    Article  CAS  Google Scholar 

  36. Jones, T. A., Zhou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991)

    Article  Google Scholar 

  37. Jameson, D. M. & Eccleston, J. F. Fluorescent nucleotide analogs: synthesis and applications. Methods Enzymol. 278, 363–390 (1997)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Work in both laboratories was supported by the Medical Research Council (UK). D.C. acknowledges support from the EC. We are grateful to N. Justin and I. Taylor for MALS analysis, and S. Smerdon for discussions.

Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 2V8Q, 2V92 and 2V9J.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Stephen R. Martin, David Carling or Steven J. Gamblin.

Ethics declarations

Competing interests

Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Supplementary information

Supplementary Information

The file contains Supplementary Tables 1-2, Supplementary Figures 1-7 with Legends and additional references. (PDF 3431 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, B., Heath, R., Saiu, P. et al. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496–500 (2007). https://doi.org/10.1038/nature06161

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature06161

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing